SCHEMBL4347661

SCHEMBL4347661

Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)C(O)[Na])c2cc1C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.79
▸ KMT2A Q03164 7/20 0.79
▸ USP2 O75604 4/20 0.79
▸ KDM4E B2RXH2 4/20 0.79
▸ HAT1 O14929 4/20 0.79
▸ RBBP7 Q16576 4/20 0.79
▸ HTT P42858 4/20 0.79
▸ RECQL P46063 3/20 0.79
▸ CASP7 P55210 3/20 0.79
▸ MAPT P10636 3/20 0.79
▸ CASP1 P29466 2/20 0.79
▸ BRCA1 P38398 2/20 0.79
▸ HSD17B10 Q99714 2/20 0.79
▸ TST Q16762 2/20 0.79
▸ TDP1 Q9NUW8 2/20 0.79
▸ ALDH1A1 P00352 2/20 0.79
▸ LMNA P02545 1/20 0.79
▸ HBB P68871 1/20 0.79
▸ CYP1A2 P05177 1/20 0.79
▸ CYP3A4 P08684 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11408067 0.90 MEN1 (0.96) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL7707 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL13373926 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL7706 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL9609755 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
SCHEMBL25166750 0.88 MEN1 (0.80) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL2420598 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL5899262 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL12979917 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1
Riboflavin SCHEMBL14146654 0.88 MEN1 (1.00) MEN1KMT2AUSP2KDM4EHAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2082651-A1 BEVERAGE PACKED IN CONTAINER Kao Corporation (JP) 2009-07-29 — — EP claimed
EP-4157215-A1 METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC CANNABINOIDS Athenion AG (CH) 2023-04-05 — — EP disclosed
EP-4096669-A1 USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES MetrioPharm AG (CH) 2022-12-07 — — EP disclosed
WO-2021151620-A1 USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES METRIOPHARM AG (CH) 2021-08-05 — — WO disclosed
EP-3858358-A1 USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES MetrioPharm AG (CH) 2021-08-04 — — EP disclosed
US-9777254-B2 Cell line derived from thread-sail filefish (Stephanolepis cirrhifer) INDEPENDENT ADMINISTRATIVE INSTITUTION, JAPAN AGENCY FOR MARINE-EARTH SCIENCE AND TECHNOLOGY (JP) 2017-10-03 — — US disclosed
US-20150175958-A1 CELL LINE DERIVED FROM THREAD-SAIL FILEFISH (STEPHANOLEPIS CIRRHIFER) INDEPENDENT ADMINISTRATIVE INSTITUTION, JAPAN AGENCY FOR MARINE-EARTH SCIENCE AND TECHNOLOGY (JP) 2015-06-25 — — US disclosed
US-20040151757-A1 Use of medium-chain triglycerides (MCT) for optimisation as to nutrition physiology of the fatty acid spectrum in a dietary foodstuff for diabetics HORST HEIRLER PROJEKTE ERNAHRUNG * MEDIZIN * OKOLOGIE 2004-08-05 — — US disclosed
EP-1421858-A1 Use of medium chain triglycerides (MCT) for the nutritional optimisation of the lipid composition of a dietetic product for diabetics HORST HEIRLER PROJEKTE ERNÄHRUNG*MEDIZIN*ÖKOLOGIE (DE) 2004-05-26 — — EP disclosed
Send feedback